The federal government announced plans to distribute 18.5 million doses of COVID-19 vaccines this week. The sum is lower than last week’s 21 million because there are no new doses of the Johnson & Johnson vaccine available for distribution at the moment. (Reuters)

The Food and Drug Administration has been forced to postpone hundreds of drug company inspections during the pandemic. Some public health experts believe drug inspections are essential and should not be overlooked. (The New York Times)

Takeda will buy Maverick Therapeutics for $525 million. Takeda R&D chief Andrew Plump said the company plans to file seven new therapies with the FDA, including a non-small cell lung cancer drug and a dengue vaccine. (STAT)

Eli Lilly has promoted Edgardo Hernandez into its top manufacturing post. He replaces Myles O’Neill, who departs the company after 19 years. Hernandez has been charged with overseeing development of the company’s antibody treatment for COVID-19. (Endpoints News)

Community health workers have united to fight vaccine hesitancy and misinformation among farmworkers. Many of the group’s concerns stem from a distrust of authorities and fears that vaccines contain microchips to track undocumented immigrants. (The Wall Street Journal)